![]() |
![]() |
|
|
Leadership
|
Leadership
ClearView Healthcare Partners, founded by a group of seasoned industry veterans, is a premier strategy consulting firm exclusively focused on the life sciences. We serve operating companies within the pharmaceutical, biotechnology, medical device and diagnostics sectors of the healthcare field.
Richard M. Mynahan, Jr., M.B.A., Partner
Prior to founding ClearView, Mr. Mynahan held leadership roles at several leading consultancies, including at Leerink Swann, Strategic Decisions Group, where he was head of the Boston office, and Arthur D. Little. Prior to his consulting career, Mr. Mynahan was a banker specializing in a range of transaction types across the healthcare field. As a member of what is now the Bank of America Healthcare Team, he participated in more than 40 deals representing multiple billions of transaction value. He holds a B.A. in economics, cum laude, from the College of the Holy Cross, and an M.B.A. with honors from the Johnson Graduate School of Management at Cornell University. Kevin P. Richard, M.B.A.
Prior to co-founding ClearView, Mr. Richard was Managing Director and co-founder of Leerink Swann Strategic Advisors. In addition, he served as a Director in the consulting practice at Decision Resources, as an Associate Compliance Auditor at Astra USA, Inc. and was Director of Ocular Allergy at Ophthalmic Research Associates (ORA). In his role at ORA and as a result of research conducted at the Schepens Eye Research Institute, he coauthored numerous abstracts, reviews, and chapters. Mr. Richard received his M.B.A. with honors from the F.W. Olin Graduate School of Business at Babson College and his Bachelor of Science from the University of New Hampshire. Steven Chao, M.D., Ph.D., Partner
He joins ClearView from Leerink Swann Strategic Advisors, where he was a Vice President. He joined Leerink Swann in 2004 from McKinsey and Company, where he led strategic engagements in the biopharmaceutical, payer, and provider industries. He received his M.D. and his Ph.D. from Harvard Medical School. He has published over 20 peer-reviewed articles and led neuroscience research in the laboratories of Dr. Lawrence Benowitz and Dr. Jonathan Seidman. He graduated summa cum laude with his B.A. in Biochemistry from Harvard College. Chris Von Seggern, Ph.D., M.P.H. M.B.A., Principal
He has worked broadly across multiple therapeutic areas, with emphasis in cardiology, metabolics, CNS, GI, ID and orphan diseases. He joins Clearview from Leerink Swann Strategic Advisors, prior to which he served as an AAAS Science Policy Fellow at the NIH, within the National Institute of Diabetes, Digestive, and Kidney Diseases. He received his Ph.D. in pharmacology and molecular sciences and his Master of Public Health from Johns Hopkins University School of Medicine. Dr. Von Seggern received his MBA from Northeastern University. He holds a B.S. in biochemistry and molecular biology from The Pennsylvania State University. |
|
ClearView Healthcare Partners |
One Newton Place, 275 Washington Street, Suite 405 • Newton, MA 02458 • 617.340.2380• info@clearviewhcp.com |
|